🔎 Trials Near Me

Home › Oropharyngeal Cancer › New Jersey

Oropharyngeal Cancer clinical trials in New Jersey

8 studies for Oropharyngeal Cancer are looking for participants at sites in New Jersey.

Cities in New Jersey

Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer

  • Cooper Hospital University Medical Center, Camden
  • Jersey City Medical Center, Jersey City
  • Cooperman Barnabas Medical Center, Livingston
  • and 4 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 5, 2026 · NCT07195734

Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer

  • Rutgers Cancer Institute of New Jersey, New Brunswick
  • Rutgers New Jersey Medical School, Newark
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT05172245

E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers

  • Rutgers Cancer Institute, New Brunswick
  • RWJBarnabas Health - Robert Wood Johnson University Hospital, New Brunswick
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jun 12, 2026 · NCT05639972

E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers

  • Rutgers Cancer Institute, New Brunswick
  • RWJBarnabas Health - Robert Wood Johnson University Hospital, New Brunswick
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jun 12, 2026 · NCT05686226

A Study of Reduced Radiation Therapy With Chemotherapy in People With HPV-Positive Throat Cancer

  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
RecruitingPhase 2
Ages 18 and older · All sexes · Updated May 11, 2026 · NCT06984861

A Study of Reduced Radiation Therapy and Standard-of-Care Chemotherapy in People With HPV-Positive Throat Cancer

  • Memorial Sloan Kettering Cancer Center at Basking Ridge (Limited Protocol Activities), Basking Ridge
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Apr 23, 2026 · NCT05491512

A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papilloma Virus (HPV)- Associated Oropharynx Cancer (OPC)

  • Memorial Sloan Kettering Basking Ridge (Limited protocol activities), Basking Ridge
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Apr 13, 2026 · NCT05307939

A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)

  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Feb 19, 2026 · NCT07063212

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.